Key Issues
-
Market Consolidation
State merger review authority, conditional approvals, cross-market systems, enforcement actions and timeline -
Provider Rate Regulation
Cost-growth benchmark, public option, affordability standards, rate caps, global budgets, population-based model -
Provider Contracts
Anticompetitive contract terms including MFN, all-or-nothing, noncompete, anti-steering, anti-tiering clauses -
Price Transparency
Cost-growth benchmark, public option, affordability standards, rate caps, global budgets, population-based model
browse key issues by
State Action
The Source tracks state activities impacting healthcare price and competition in both legislation (The Database of State Laws Impacting Healthcare Cost and Quality) and litigation in a searchable database to help stakeholders at the state level understand their legal and regulatory environment as they make efforts to improve access, quality, and efficiency, and reduce costs in healthcare.
Browse through the maps below to find out more about notable legislation and initiatives in health policy and reform across 50 states or search the database for specific laws and cases of a particular state.
The Source Blog
Bruce Allain, Managing Editor
December 4, 2024
News & Opinions
Katie PalmerDecember 5, 2024
Nathan BomeyDecember 5, 2024
Hayley DeSilvaDecember 4, 2024
Hayley DeSilvaDecember 4, 2024
Sarah KliffDecember 4, 2024
Nathan BomeyDecember 5, 2024
Hayley DeSilvaDecember 4, 2024
Hayley DeSilvaDecember 4, 2024
Sarah KliffDecember 4, 2024
Articles & Reports
Health Affairs
November 4, 2024
Health Affairs November 4, 2024
Health Affairs Scholar November 1, 2024
Health Affairs Forefront November 1, 2024
Health Affairs November 4, 2024
Health Affairs Scholar November 1, 2024
Health Affairs Forefront November 1, 2024
Source Sightings
As Hospitals Grow, So Does Your Bill
Jaime S King, Katherine L Gudiksen, Thomas L Greaney
June 6, 2024
New evidence on the impacts of cross-market hospital mergers on commercial prices and measures of quality
Jaime S. King, Katie Gudiksen, Thomas L. Greaney
April 23, 2024
Pharma Litigation Threatens to Limit State Drug Pricing Policy
Katie Gudiksen
January 30, 2024